- CA$68.27bn
- CA$81.95bn
- CA$49.09bn
- 83
- 83
- 95
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 38,344 | 24,662 | 39,132 | 58,336 | 49,092 |
Cost of Revenue | |||||
Gross Profit | 25,782 | 15,550 | 25,341 | 37,561 | 30,877 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36,353 | 30,472 | 32,927 | 44,443 | 39,289 |
Operating Profit | 1,991 | -5,810 | 6,205 | 13,893 | 9,803 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,533 | -6,097 | 5,570 | 12,316 | 10,589 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,899 | -4,319 | 4,119 | 9,077 | 8,295 |
Net Income Before Extraordinary Items | |||||
Net Income | 2,899 | -4,319 | 4,119 | 9,077 | 8,295 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,899 | -4,319 | 4,119 | 9,077 | 8,295 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.52 | -1.88 | 2.66 | 8.03 | 5.48 |
Dividends per Share |